Target Name: H2BC27P
NCBI ID: G337872
Review Report on H2BC27P Target / Biomarker Content of Review Report on H2BC27P Target / Biomarker
H2BC27P
Other Name(s): Histone cluster 3, H2ba, pseudogene | H2B clustered histone 27, pseudogene | H2BU2P | HIST3H2BA

H2BC27P: A Potential Drug Target and Biomarker

Histone cluster 3 (H2BC27P), also known as pseudogene H2ba, is a protein that plays a critical role in the regulation of gene expression and cell development. H2BC27P is a 27 kDa protein that is composed of two distinct subunits, H2B伪 and H2B尾. In this article, we will discuss the research on H2BC27P as a drug target and its potential utility as a biomarker.

H2BC27P is a histone that is involved in the regulation of gene expression and cell development. It is a key player in the histone-DNA complex, which is responsible for the regulation of gene expression. H2BC27P plays a critical role in the regulation of gene expression by modulating the accessibility of gene promoters to transcription factors.

H2BC27P has been shown to be involved in the regulation of cell development and has been linked to the development and progression of various diseases, including cancer. For example, studies have shown that H2BC27P is involved in the regulation of cell proliferation and has been associated with the development of cancer. Additionally, H2BC27P has been shown to be involved in the regulation of cell apoptosis, and its levels have been linked to the sensitivity of cancer cells to chemotherapy.

H2BC27P has also been shown to be a potential drug target. Several studies have shown that H2BC27P can be targeted by small molecules and antibodies, and that these treatments can inhibit its activity. For example, studies have shown that inhibition of H2BC27P with small molecules can inhibit the activity of various transcription factors, including nuclear factor NF-kappa-B, and cause a decrease in cell proliferation.

Another study has shown that antibodies against H2BC27P can inhibit its activity and cause a decrease in the growth of cancer cells. This suggests that H2BC27P may be a useful biomarker for the treatment of cancer.

In addition to its potential as a drug target, H2BC27P has also been shown to be a potential biomarker for the diagnosis and monitoring of various diseases. Studies have shown that H2BC27P levels can be used as a biomarker for the diagnosis of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, H2BC27P has been shown to be involved in the regulation of pain perception and has been linked to the development of chronic pain.

In conclusion, H2BC27P is a protein that plays a critical role in the regulation of gene expression and cell development. Its involvement in the regulation of gene expression and cell apoptosis makes it a potential drug target. Additionally, H2BC27P has also been shown to be a potential biomarker for the diagnosis and monitoring of various diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the role of H2BC27P as a drug target and its potential as a biomarker.

Protein Name: H2B Clustered Histone 27, Pseudogene

The "H2BC27P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H2BC27P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3